Is immunoproliferative small intestinal disease uncommon in India?

Ghoshal, U C; Chetri, K; Banerjee, P K; Choudhuri, G; Pal, B B; Dabadghao, S; Dhar, K; Naik, S; Naik, S R

Ghoshal, U C; Chetri, K; Banerjee, P K; Choudhuri, G; Pal, B B; Dabadghao, S; Dhar, K; Naik, S; Naik, S R.

Article in En | IMSEAR | ID: sea-124907

Subject(s)

Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Cyclophosphamide/therapeutic use; Doxorubicin/therapeutic use; Humans; Immunoproliferative Small Intestinal Disease/diagnosis; India/epidemiology; Middle Aged; Prednisolone/therapeutic use; Prognosis; Tetracycline/therapeutic use; Vincristine/therapeutic use

Fulltext

Add to My VHL

XML

Search on Google

Full text: 1 Index: IMSEAR Main subject: Prognosis / Tetracycline / Vincristine / Immunoproliferative Small Intestinal Disease / Humans / Prednisolone / Antineoplastic Combined Chemotherapy Protocols / Doxorubicin / Adolescent / Adult Type of study: Prognostic_studies / Screening_studies Country/Region as subject: Asia Language: En Year: 2001 Type: Article

Fulltext

Add to My VHL

XML

Search on Google